ADVERTISEMENT
News
Heartburn Drug Recalled
11/08/2019
The recall spans nearly 70,000 bottles of 8-count ranitidine tablets (NDC 55910-092-79) from lot NBSB19001DA3 (Exp. 2/21). The bottles were distributed by Dolgencorp throughout the United States.
AuroMedics Pharma voluntarily initiated the recall September 23, 2019. On October 29, 2019, the FDA designated the recall Class III, signaling use of the product is not likely to cause harm.
Ranitidine is an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.
—Jolynn Tumolo